GATC Health
The AI engine Fit Assessment
BetaGATC Health effectively leverages machine learning to discover health patterns and expand therapeutics, while also utilizing its platform for potential drug repurposing.
Blurb
AI platform transforming drug discovery & development.
HQ Location
Irvine (United States)
Founded
2020
Employees
11 - 50
Total funding raised
$5.41M
Last Funding Event
Seed, $240.00K, August 23, 2023
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
GATC Health is an AI company transforming drug development and disease prediction. GATC’s Multiomics Advanced Technology™ (MAT) AI replicates complex systems biology using all data types to accurately predict efficacy, safety, and off-target effects. GATC is transforming the future of medicine with significantly increased accuracy, efficiency, and speed.